Top Markets
Coin of the day
Lushang Freda Pharmaceutical Co.,Ltd. Lushang Freda Pharmaceutical Co.,Ltd.

Lushang Freda Pharmaceutical Co.,Ltd.

600223
Rangering i aksjer #10388
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development,... Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.
Aksjekurs
$0.83325484
Sist synkronisert: 2026-08-28
Markedsverdi
$847.06M
Endring (1 dag)
0.70%
Endring (1 år)
-26.10%
Land
CN
Handel Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Kategori

P/B-forhold for Lushang Freda Pharmaceutical Co.,Ltd. (600223)
P/B-forhold per 2026 TTM: 0
Ifølge Lushang Freda Pharmaceutical Co.,Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Lushang Freda Pharmaceutical Co.,Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter